Category: New products

  • Cough Diagnostics Mobile App in Clinical Trial

    22 July 2015. A smartphone app designed to diagnose the nature of a cough by the sound it makes is now being tested in a clinical trial in Australia. The app, developed in the lab of engineering professor Udantha Abeyratne at University of Queensland in Brisbane, Australia was licensed to a spin-off company from the…

  • Navy Seeks Graphene Nanoribbons for Electricity Distribution

    20 July 2015. The U.S. Navy wants a more efficient way to distribute electric power on its ships, and believes ultrathin ribbons made of graphene may help them do it. The Office of Naval Research awarded an $800,000 grant to the lab led by engineering professor Cemal Basaran at University at Buffalo to find out more…

  • Early Test Shows Alzheimer’s Candidate Lowers Brain Deposits

    20 July 2015. A drug developed to treat Alzheimer’s disease reduced a large percentage of accumulated harmful peptides and proteins in brains of laboratory mice induced with the disorder. Results of the tests were reported today by the biotechnology company Treventis Corp. in Philadelphia, developer of the drug code-named TRV-101. Alzheimer’s disease is progressive neurodegenerative…

  • Wireless System Developed to Deliver Drugs to Brain

    17 July 2015. Engineers and medical researchers designed and tested in animals a system that implants drugs for the brain in ultra-thin optical cables, then triggers their release through wireless signals. The proof-of-concept system, developed at Washington University in St. Louis and University of Illinois in Urbana, is described in yesterday’s issue of the journal…

  • Genetic Engineered Variety Controls Destructive Moth

    16 July 2015. A genetically engineered diamondback moth that prevents females of the species from maturing is found in greenhouse tests to quickly control populations of this destructive pest. Results of the tests, led by biotechnology company Oxitec Ltd., appear today in the journal BMC Biology. The diamondback moth — Plutella xylostella — is a…

  • Magnetic Nanoparticles Found to Boost Immunotherapy

    15 July 2015. Researchers at Johns Hopkins University designed a process for making immunotherapy more practical as a cancer treatment by collecting cancer-fighting T-cells faster and easier with magnetic synthetic antigen nanoparticles. The team from the lab of Jonathan Schneck, professor of pathology at Johns Hopkins University medical center in Baltimore, published results of lab…

  • Process Adds Antimicrobial Silver Particles to Plants

    14 July 2015. Engineers at North Carolina State University developed a process that adds biodegradable nanoparticles infused with silver to plant fibers that can kill a broad range of bacteria. A team from the lab of chemical engineering professor Orlin Velev, with colleagues from the U.S. Environmental Protection Agency and institutions in the U.K. and…

  • Spinal Stimulation Start-Up Wins $200K State Award

    13 July 2015. PathMaker Neurosystems Inc., a developer of non-invasive devices that stimulate the spinal cord to relieve muscle weakness and paralysis, received a $200,000 award from a Massachusetts science funding agency. The grant was made by Massachusetts Life Sciences Center as part of its life sciences milestone achievement program. PathMaker’s technology uses electronic current…

  • Antibodies Isolated for Chikungunya Virus

    9 July 2015. Researchers at Vanderbilt University in Nashville isolated 13 antibodies from a person infected with the chikungunya virus shown to possibly prevent and treat infections in lab mice. The team led by James Crowe, director of Vanderbilt’s Vaccine Center, published its findings yesterday in the journal Cell Host & Microbe. Chikungunya is a disease…

  • FDA Grants Orphan Status to Brain Cancer Surgery Aid

    7 July 2015. The U.S. Food and Drug Administration is granting orphan drug status to an engineered peptide that illuminates brain cancer cells making them easier to surgically remove. The treatment, code-named BLZ-100, is made by Blaze Bioscience, a biotechnology company in Seattle. Blaze Bioscience is a spin-off enterprise from Fred Hutchinson Cancer Research Center,…